|
MSF Field Research >
1 Published Research and Commentary >
HIV/AIDS >
Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studies.
Please use
this identifier to cite or link
to this item:
http://hdl.handle.net/10144/255348
Del.icio.us
LinkedIn
Citeulike
Connotea
Facebook
Stumble it!
| Title: | Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studies. |
| Authors: | Wandeler, Gilles Keiser, Olivia Mulenga, Lloyd Hoffmann, Christopher J Wood, Robin Chaweza, Thom Brennan, Alana Prozesky, Hans Garone, Daniela Giddy, Janet Chimbetete, Cleophas Boulle, Andrew Egger, Matthias |
| Affiliation: | Division of International and Environmental Health, Institute of Social and Preventive Medicine, University of Bern, Finkenhubelweg 11, CH-3012 Bern, Switzerland. gwandeler@ispm.unibe.ch |
| Citation: | Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studies. 2012, 61 (1):41-8 J. Acquir. Immune Defic. Syndr. |
| Journal: | Journal of acquired immune deficiency syndromes (1999) |
| Issue Date: | 1-Sep-2012 |
| URI: | http://hdl.handle.net/10144/255348 |
| DOI: | 10.1097/QAI.0b013e3182632540 |
| PubMed ID: | 22743595 |
| Additional Links: | http://www.ncbi.nlm.nih.gov/pubmed/22743595 |
| Abstract: | Tenofovir (TDF) is increasingly used in second-line antiretroviral treatment (ART) in sub-Saharan Africa. We compared outcomes of second-line ART containing and not containing TDF in cohort studies from Zambia and the Republic of South Africa (RSA). |
| Type: | Article |
| Language: | en |
| Description: | Article approval pending |
| Keywords: | HIV/AIDS |
| MeSH: | Adenine Adult Africa South of the Sahara Anti-Retroviral Agents Antiretroviral Therapy, Highly Active CD4 Lymphocyte Count Cohort Studies Female HIV Infections Humans Male Middle Aged Phosphonic Acids South Africa Treatment Outcome Viral Load Zambia |
| ISSN: | 1944-7884 |
| Rights: | Archived with thanks to Journal of Acquired Immune Deficiency Syndromes (1999) |
| Appears in topics: | HIV/AIDS
|
| Related articles on PubMed |  | Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia.Chi BH, Mwango A, Giganti M, Mulenga LB, Tambatamba-Chapula B, Reid SE, Bolton-Moore C, Chintu N, Mulenga PL, Stringer EM, Sheneberger R, Mwaba P, Stringer JS 2010 May 1 |
|  | Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa.Keiser O, Chi BH, Gsponer T, Boulle A, Orrell C, Phiri S, Maxwell N, Maskew M, Prozesky H, Fox MP, Westfall A, Egger M, IeDEA Southern Africa Collaboration 2011 Sep 10 |
|  | Comparative outcomes of tenofovir-based and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia.Chi BH, Mwango A, Giganti MJ, Sikazwe I, Moyo C, Schuttner L, Mulenga LB, Bolton-Moore C, Chintu NT, Sheneberger R, Stringer EM, Stringer JS 2011 Dec 15 |
| | | | See all 117 articles |
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.
|